Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Phibro Animal Health (PAHC) Acquisitions (2016 - 2025)

Phibro Animal Health has reported Acquisitions over the past 8 years, most recently at -$5.3 million for Q2 2025.

For Q2 2025, Acquisitions changed N/A year-over-year to -$5.3 million; the TTM value through Jun 2025 reached -$4.3 million, down 261.88%, while the annual FY2025 figure was $286.5 million, 8630.32% up from the prior year.
Acquisitions for Q2 2025 was -$5.3 million at Phibro Animal Health, down from $1.1 million in the prior quarter.
Over five years, Acquisitions peaked at $2.7 million in Q2 2022 and troughed at -$5.3 million in Q2 2025.
A 3-year average of -$403750.0 and a median of $504500.0 in 2024 define the central range for Acquisitions.
On a YoY basis, Acquisitions climbed as much as 2493.18% in 2025 and fell as far as 2493.18% in 2025.
Year by year, Acquisitions stood at $2.7 million in 2022, then plummeted by 101.61% to -$44000.0 in 2024, then plummeted by 12056.82% to -$5.3 million in 2025.
Business Quant data shows Acquisitions for PAHC at -$5.3 million in Q2 2025, $1.1 million in Q1 2025, and -$44000.0 in Q1 2024.